{"id":"W4323352826","doi":"10.1200/jco.22.01972","title":"MANIFEST: Pelabresib in Combination With Ruxolitinib for Janus Kinase Inhibitor Treatment-Naïve Myelofibrosis","year":2023,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; Medical Research Council; Cancer Research UK","keywords":"Medicine; Ruxolitinib; Myelofibrosis; Discontinuation; Internal medicine; Gastroenterology; Cohort; Clinical endpoint; Surgery; Clinical trial; Bone marrow","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001438653,0.0002078687,0.001466286,0.0003114253,0.00005865399,0.0000151715,0.0000771546,0.0003047253,0.00006358646],"category_scores_gemma":[0.00149721,0.0001295927,0.0003976636,0.0003020333,0.0001157533,0.0001158368,0.000021952,0.0003368505,0.00004726055],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004296767,"about_ca_system_score_gemma":0.001205878,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000343841,"about_ca_topic_score_gemma":0.0002028781,"domain_scores_codex":[0.997063,0.0002715342,0.001750289,0.0002673285,0.0003176848,0.0003301942],"domain_scores_gemma":[0.9942204,0.003845309,0.000967496,0.0001626965,0.000463315,0.0003408],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01773003,0.01212198,0.7355753,0.0001070117,0.0008944557,0.004008695,0.0004892224,0.00004091561,0.0001900707,0.001996659,0.007007154,0.2198385],"study_design_scores_gemma":[0.04648079,0.08596678,0.810272,0.0003317106,0.0005440967,0.0003142065,0.0003416483,0.000204794,0.001252994,0.0007401241,0.05340089,0.0001500211],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9816464,0.0001520091,0.00003281108,0.01516247,0.0006035311,0.0008716294,0.00002073539,0.00002087749,0.001489603],"genre_scores_gemma":[0.9930162,0.000928675,0.003322658,0.0007485406,0.0008937923,0.0001349226,0.00003865068,0.00003012383,0.0008863791],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2196885,"threshold_uncertainty_score":0.5284638,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1404993595302603,"score_gpt":0.4583511375790651,"score_spread":0.3178517780488048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}